RadNet (RDNT) Competitors $59.86 -1.02 (-1.68%) Closing price 04:00 PM EasternExtended Trading$59.66 -0.20 (-0.33%) As of 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RDNT vs. FMS, HIMS, OPCH, GH, SHC, VCYT, BTSG, LFST, SGRY, and CONShould you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. RadNet vs. Fresenius Medical Care Hims & Hers Health Option Care Health Guardant Health Sotera Health Veracyte BrightSpring Health Services LifeStance Health Group Surgery Partners Concentra Group Holdings Parent RadNet (NASDAQ:RDNT) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, community ranking, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations. Which has more volatility and risk, RDNT or FMS? RadNet has a beta of 1.79, suggesting that its stock price is 79% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Which has stronger valuation & earnings, RDNT or FMS? Fresenius Medical Care has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.62B2.74$3.04M-$0.07-855.02Fresenius Medical Care$21.05B0.64$540.07M$1.2119.08 Is RDNT or FMS more profitable? Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-0.25% 4.29% 1.45% Fresenius Medical Care 3.43%6.04%2.69% Do institutionals & insiders have more ownership in RDNT or FMS? 77.9% of RadNet shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer RDNT or FMS? Fresenius Medical Care received 71 more outperform votes than RadNet when rated by MarketBeat users. However, 66.10% of users gave RadNet an outperform vote while only 54.66% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformRadNetOutperform Votes35166.10% Underperform Votes18033.90% Fresenius Medical CareOutperform Votes42254.66% Underperform Votes35045.34% Does the media prefer RDNT or FMS? In the previous week, RadNet had 7 more articles in the media than Fresenius Medical Care. MarketBeat recorded 7 mentions for RadNet and 0 mentions for Fresenius Medical Care. RadNet's average media sentiment score of 0.63 beat Fresenius Medical Care's score of 0.00 indicating that RadNet is being referred to more favorably in the media. Company Overall Sentiment RadNet Positive Fresenius Medical Care Neutral Do analysts recommend RDNT or FMS? RadNet currently has a consensus target price of $79.75, suggesting a potential upside of 33.23%. Fresenius Medical Care has a consensus target price of $25.30, suggesting a potential upside of 9.57%. Given RadNet's stronger consensus rating and higher probable upside, analysts plainly believe RadNet is more favorable than Fresenius Medical Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Fresenius Medical Care 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 SummaryRadNet beats Fresenius Medical Care on 11 of the 19 factors compared between the two stocks. Get RadNet News Delivered to You Automatically Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDNT vs. The Competition Export to ExcelMetricRadNetMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.43B$2.96B$5.36B$9.14BDividend YieldN/A16.03%5.13%4.04%P/E Ratio-855.0215.3489.4717.33Price / Sales2.74200.681,263.70136.49Price / Cash20.65426.0143.7535.97Price / Book5.084.925.324.80Net Income$3.04M-$33.85M$122.60M$224.91M7 Day Performance-12.97%1.54%0.69%1.77%1 Month Performance-21.77%-4.33%1.55%2.22%1 Year Performance64.95%10.49%27.25%20.67% RadNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDNTRadNet4.2986 of 5 stars$59.86-1.7%$79.75+33.2%+66.2%$4.43B$1.62B-855.0210,288Analyst ForecastNews CoverageFMSFresenius Medical Care3.4209 of 5 stars$22.25-1.1%$25.30+13.7%+18.2%$13.06B$19.24B18.391,358HIMSHims & Hers Health3.3285 of 5 stars$25.55+0.6%$25.13-1.6%+229.9%$5.58B$1.24B58.071,046Insider TradeShort Interest ↑Gap DownOPCHOption Care Health4.7517 of 5 stars$27.60+15.0%$29.71+7.7%-9.2%$4.70B$4.78B23.195,600Analyst ForecastShort Interest ↓Analyst RevisionPositive NewsGHGuardant Health3.9692 of 5 stars$37.59+2.4%$40.60+8.0%+58.4%$4.64B$692.26M-8.871,779Short Interest ↓SHCSotera Health4.038 of 5 stars$12.98-1.0%$16.08+23.9%-16.6%$3.68B$1.12B51.923,000VCYTVeracyte4.0778 of 5 stars$42.52+2.4%$41.13-3.3%+54.4%$3.30B$425.33M-283.47790Positive NewsBTSGBrightSpring Health Services2.1249 of 5 stars$17.22+0.3%$18.65+8.3%N/A$3.00B$10.59B-66.2335,000Positive NewsLFSTLifeStance Health Group1.1608 of 5 stars$7.69-0.5%$8.70+13.1%+16.5%$2.94B$1.21B-29.589,325Short Interest ↓Positive NewsSGRYSurgery Partners2.2487 of 5 stars$20.81+0.8%$36.56+75.7%-36.9%$2.65B$2.99B-43.3512,200CONConcentra Group Holdings ParentN/A$20.53+4.1%$28.50+38.8%N/A$2.61B$1.88B0.0011,000Lockup ExpirationNews CoveragePositive NewsGap Down Related Companies and Tools Related Companies Fresenius Medical Care Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives Guardant Health Alternatives Sotera Health Alternatives Veracyte Alternatives BrightSpring Health Services Alternatives LifeStance Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RDNT) was last updated on 1/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.